USP Methods for the Analysis of Aminocaproic Acid using the Legacy L1 Column

  Application Notes: Aminocaproic acid is a enzymatic inhibitor. According to USP methods, aminocaproic acid conatins not less than 98.5% and not more than 101.5% of aminocaproic acid calculated on a dried basis. The USP HPLC method for the separation of aminocaproic acid was developed on Legacy L1 column according to the US Pharmacopeia methodology. L1 classification is assigned to reversed-phase HPLC column containing C18 ligand. Support for the material is spherical silica gel with particles size 3-10 um and pore size of 100-120A. Resolution between critical pairs corresponds to rules and specifications of UPS.   Application Columns: Legacy L1 C18 HPLC column Application compounds: Aminocaproic acid Mobile phase: Sodium heptanesulfonate/H2O/MeOH /NaH2PO4 pH 2.2 Detection technique: UV Reference: USP35: NF30

Condition

Column Legacy L1, 4.6x150 mm, 5 µm, 100A
Mobile Phase Sodium heptanesulfonate/H2O/MeOH /NaH2PO4 pH 2.2
Flow Rate 0.7 ml/min
Detection UV, 210 nm
 

Description

Class of Compounds Drug, Clotting promoter, Hydrophilic, Ionizable
Analyzing Compounds Aminocaproic Acid
 
SIELC Technologies usually develops more than one method for each compound on our website. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound of interest.
Application Analytes:
Aminocaproic acid

Application Detection:
UV Detection